Teza Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Teza Capital Management's DGX Position: Q3 2024 in Review
Teza Capital Management sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 2,561 shares — an estimated $351K sold.
Teza Capital Management first reported a position in DGX in Q1 2018 and held it in 14 quarters. The position peaked at $1.58M in Q2 2020. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.
- Teza Capital Management reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
- Teza Capital Management sold 2,561 Quest Diagnostics shares in Q3 2024, an estimated $351K.
- Teza Capital Management first reported a position in Quest Diagnostics in Q1 2018 and held it in 14 quarters.
- Teza Capital Management's Quest Diagnostics position peaked at $1.58M in Q2 2020.
- 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.
Based on Teza Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.